Skip to main content
ChoA Pharmaceutical Co., LTD. logo

ChoA Pharmaceutical Co., LTD. — Investor Relations & Filings

Ticker · 034940 ISIN · KR7034940007 KO Manufacturing
Open in API
Filings indexed 115 across all filing types
Latest filing 2020-03-05 Proxy Solicitation & In…
Country KR South Korea
Listing KO 034940

About ChoA Pharmaceutical Co., LTD.

https://www.choa.co.kr/en/

ChoA Pharmaceutical Co., LTD., established in 1988, is a company engaged in the development, manufacturing, and sale of pharmaceutical products and health supplements. The company's portfolio comprises approximately 200 products, including over-the-counter (OTC) drugs, generic medications, and functional health foods. It offers a diverse range of formulations such as tablets, capsules, granules, ampoules, and a notable selection of liquid and drinkable products. ChoA Pharmaceutical primarily supplies pharmacies and maintains a global business presence, exporting its products to more than 20 countries. The company focuses on developing high-quality medicines and health-related products to contribute to public well-being.

Recent filings

Filing Released Lang Actions
주주총회소집공고
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal 'Notice of Annual General Meeting' (주주총회소집공고) for Cho-A Pharm. Co., Ltd. It contains the meeting agenda, details on director appointments, remuneration limits, and voting procedures (including electronic voting). This document is provided to shareholders to inform them of the upcoming meeting and solicit their votes, which aligns perfectly with the definition of a Proxy Solicitation & Information Statement.
2020-03-05 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a 'Proxy Solicitation' (위임권유) for the 24th Annual General Meeting of Cho-A Pharm Co., Ltd. It contains details regarding the agenda items for the shareholder meeting, such as the appointment of directors and the approval of remuneration limits for directors. It provides information to shareholders to solicit their votes (proxy) for the upcoming meeting. This fits the definition of a Proxy Solicitation & Information Statement (PSI).
2020-02-27 Korean
매출액또는손익구조30%(대규모법인은15%)이상변동
Management Reports Classification · 1% confidence The document is a regulatory filing from the Korea Exchange (KRX) regarding a significant change in financial results (revenue or profit/loss structure) for Cho-A Pharm. It provides a comparative table of financial data (revenue, operating profit, net income) between the current and previous fiscal years and explains the reasons for the variance. This type of disclosure is a standard regulatory requirement for listed companies to announce material financial changes before the final audit report is published. It fits the definition of an Earnings Release (ER) as it provides the initial announcement of key financial highlights.
2020-02-24 Korean
주주총회소집결의
Proxy Solicitation & Information Statement Classification · 1% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Cho-A Pharm. It outlines the date, location, and agenda items for the upcoming Annual General Meeting, including the election of directors and approval of remuneration. This type of document is a standard proxy solicitation/notice of meeting provided to shareholders to inform them of the upcoming vote, which falls under the Proxy Solicitation & Information Statement category.
2020-02-24 Korean
전환청구권행사(제3회차)
Share Issue/Capital Change Classification · 1% confidence The document is a formal regulatory filing from Joa Pharm regarding the exercise of conversion rights (전환청구권행사) for convertible bonds (CB). It details the number of shares issued, the conversion price, and the remaining balance of the convertible bonds. This type of filing relates to changes in capital structure due to the conversion of debt into equity, which falls under the 'Share Issue/Capital Change' category.
2020-02-03 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and contractual obligations (such as collateral/pledges) of major shareholders (Cho Seong-hwan and special related parties) in Cho-A Pharmaceutical Co., Ltd. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2020-01-22 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.